PT3106176T - Compostos de alumínio para utilização em produtos terapêuticos e vacinas - Google Patents

Compostos de alumínio para utilização em produtos terapêuticos e vacinas

Info

Publication number: PT3106176T
Authority: PT; Portugal
Prior art keywords: vaccines; aluminum compounds; therapeutic products; therapeutic; products
Prior art date: 2011-12-06

Application number

PT161830765T

Other languages

English (en)

Inventor

Möhlen Michael

Weber Michael

Wruss Jürgen

Schlegl Robert

Original Assignee

Valneva Austria Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-12-06

Filing date

2012-12-06

Publication date

2017-12-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47294919&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3106176(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-03-13 Priority claimed from PCT/EP2012/054387 external-priority patent/WO2013135274A1/en

2012-12-06 Application filed by Valneva Austria Gmbh filed Critical Valneva Austria Gmbh

2017-12-20 Publication of PT3106176T publication Critical patent/PT3106176T/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Immunology (AREA)
Microbiology (AREA)
Mycology (AREA)
Inorganic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Virology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)

PT161830765T 2011-12-06 2012-12-06 Compostos de alumínio para utilização em produtos terapêuticos e vacinas PT3106176T (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP11192230		2011-12-06
PCT/EP2012/054387 WO2013135274A1 (en)	2012-03-13	2012-03-13	Aluminium compounds for use in therapeutics and vaccines

Publications (1)

Publication Number	Publication Date
PT3106176T true PT3106176T (pt)	2017-12-20

Family

ID=47294919

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PT161830765T PT3106176T (pt)	2011-12-06	2012-12-06	Compostos de alumínio para utilização em produtos terapêuticos e vacinas
PT171855265T PT3269386T (pt)	2011-12-06	2012-12-06	Compostos de alumínio para utilização em terapêuticas e vacinas

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PT171855265T PT3269386T (pt)	2011-12-06	2012-12-06	Compostos de alumínio para utilização em terapêuticas e vacinas

Country Status (16)

Country	Link
EP (5)	EP3106176B1 (pt)
CY (1)	CY1119927T1 (pt)
DE (1)	DE202012012768U1 (pt)
DK (6)	DK3269386T3 (pt)
ES (3)	ES2930458T3 (pt)
FI (1)	FI3785730T3 (pt)
HR (1)	HRP20171871T1 (pt)
HU (1)	HUE037325T2 (pt)
LT (1)	LT3106176T (pt)
NO (1)	NO3106176T3 (pt)
PL (2)	PL3106176T3 (pt)
PT (2)	PT3106176T (pt)
RS (1)	RS56709B1 (pt)
SI (1)	SI3106176T1 (pt)
SM (1)	SMT201700607T1 (pt)
WO (1)	WO2013083726A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SMT201700607T1 (it)	2011-12-06	2018-01-11	Valneva Austria Gmbh	Composti a base di alluminio per uso in agenti terapeutici ed in vaccini
US9895437B2 (en)	2012-04-18	2018-02-20	Valneva Austria Gmbh	Aluminum compounds for use in therapeutics and vaccines
US8986704B2 (en)	2012-07-06	2015-03-24	Valneva Austria Gmbh	Mutant fragments of OspA and methods and uses relating thereto
ES2788393T3 (es)	2014-09-03	2020-10-21	Intervet Int Bv	Coronavirus de bovino atenuado y vacunas relacionadas
WO2017109224A1 (en)	2015-12-23	2017-06-29	Valneva Se	Virus purification
US11951165B2 (en)	2016-12-30	2024-04-09	Vaxcyte, Inc.	Conjugated vaccine carrier proteins
CN118662649A (zh)	2016-12-30	2024-09-20	Vaxcyte公司	具有非天然氨基酸的多肽-抗原缀合物
ES2957939T3 (es)	2017-04-13	2024-01-30	Valneva Austria Gmbh	Polipéptidos de OspA multivalentes y métodos y usos relacionados con los mismos
BR112020003470B1 (pt)	2017-09-21	2023-09-26	Valneva Se	Composições farmacêuticas compreendendo o vírus imunogênico de chikungunya chikv-delta5nsp3, processo e uso das mesmas
MY193736A (en)	2017-11-03	2022-10-27	Takeda Vaccines Inc	Method for inactivating zika virus and for determining the completeness of inactivation
JP2021505549A (ja)	2017-11-30	2021-02-18	タケダワクチン, インコーポレイテッドTakeda Vaccines, Inc.	ジカワクチン及び免疫原性組成物、ならびにその使用方法
EP3820884A1 (en)	2018-07-13	2021-05-19	Valneva SE	Method for rescuing and producing a virus in avian cells
MX2021013111A (es)	2019-05-20	2021-11-17	Valneva Se	Una vacuna de subunidad para el tratamiento o la prevencion de una infeccion del tracto respiratorio.
EP4114459A4 (en) *	2020-03-01	2023-09-13	Dynavax Technologies Corporation	Coronavirus vaccines comprising a tlr9 agonist
EP3895729A1 (en)	2020-03-01	2021-10-20	Valneva Austria GmbH	Cpg-adjuvanted sars-cov-2 virus vaccine
EP4114457A4 (en) *	2020-03-01	2023-08-09	Dynavax Technologies Corporation	CORONAVIRUS VACCINES INCLUDING A TLR9 AGONIST
JP2023515908A (ja)	2020-03-01	2023-04-14	ヴァルネヴァ・オーストリア・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング	ＣｐＧアジュバント化ＳＡＲＳ－ＣｏＶ－２ウイルスワクチン
EP4114463A4 (en) *	2020-03-01	2023-09-06	Dynavax Technologies Corporation	CORONAVIRUS VACCINES INCLUDING A TLR9 AGONIST
WO2021204825A2 (en)	2020-04-06	2021-10-14	Valneva Austria Gmbh	INACTIVATED SARS-CoV-2 VIRUS VACCINE
WO2021205017A1 (en)	2020-04-09	2021-10-14	Valneva Austria Gmbh	Improvements in vaccine formulations for medical use
US20240181034A1 (en)	2021-04-09	2024-06-06	Valneva Se	Human metapneumo virus vaccine
WO2023148256A1 (en)	2022-02-02	2023-08-10	Valneva Austria Gmbh	Inactivated sars-cov-2 virus vaccine
EP4531899A1 (en)	2022-06-01	2025-04-09	Valneva Austria GmbH	Clostridium difficile vaccine
WO2024153686A1 (en)	2023-01-18	2024-07-25	Valneva Austria Gmbh	Process for virus production in a bioreactor

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4057685A (en)	1972-02-02	1977-11-08	Abbott Laboratories	Chemically modified endotoxin immunizing agent
US4761372A (en)	1981-01-12	1988-08-02	New York University	Mutant enterotoxin of E. coli
US4673574A (en)	1981-08-31	1987-06-16	Anderson Porter W	Immunogenic conjugates
US4459286A (en)	1983-01-31	1984-07-10	Merck & Co., Inc.	Coupled H. influenzae type B vaccine
US4663160A (en)	1983-03-14	1987-05-05	Miles Laboratories, Inc.	Vaccines for gram-negative bacteria
US4761283A (en)	1983-07-05	1988-08-02	The University Of Rochester	Immunogenic conjugates
US4882317A (en)	1984-05-10	1989-11-21	Merck & Co., Inc.	Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugataes and of confirming covalency
US4695624A (en)	1984-05-10	1987-09-22	Merck & Co., Inc.	Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
US4808700A (en)	1984-07-09	1989-02-28	Praxis Biologics, Inc.	Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
US5308835A (en)	1984-07-09	1994-05-03	Praxis Biologics, Inc.	Production of the E. coli LT-B enterotoxin subunit
NL8802046A (nl)	1988-08-18	1990-03-16	Gen Electric	Polymeermengsel met polyester en alkaansulfonaat, daaruit gevormde voorwerpen.
CA2059692C (en)	1991-01-28	2004-11-16	Peter J. Kniskern	Pneumoccoccal polysaccharide conjugate vaccine
CA2059693C (en)	1991-01-28	2003-08-19	Peter J. Kniskern	Polysaccharide antigens from streptococcus pneumoniae
AUPO264096A0 (en)	1996-09-30	1996-10-24	Mclaughlin Geosurveys Pty Ltd.	Value improvement of clays
US6818222B1 (en)	1997-03-21	2004-11-16	Chiron Corporation	Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
NZ503522A (en)	1997-08-28	2001-06-29	Us Army	Attenuated Japanese encephalitis virus adapted to vero cell and a Japanese encephalitis vaccine
CZ2001622A3 (cs)	1998-08-19	2002-01-16	North American Vaccine, Inc.	Imunogenní konjugát polysacharid-protein s ß-propionamidovým spojením výhodný jako vakcina produkovaná za pouľití N-akryloylovaného polysacharidu
US7527802B2 (en)	2001-02-13	2009-05-05	The United States Of America As Represented By The Secretary Of The Army	Vaccine for transcutaneous immunization
GB0118249D0 (en) *	2001-07-26	2001-09-19	Chiron Spa	Histidine vaccines
US20110189217A1 (en) *	2008-06-26	2011-08-04	Barry Michael A	Methods and materials for producing immune responses against polypeptides involved in antibiotic resistance
CN101734698B (zh)	2009-09-08	2013-01-09	东北大学	一种由含铝物料制备氧化铝的方法
SMT201700607T1 (it)	2011-12-06	2018-01-11	Valneva Austria Gmbh	Composti a base di alluminio per uso in agenti terapeutici ed in vaccini

2012
- 2012-12-06 SM SM20170607T patent/SMT201700607T1/it unknown
- 2012-12-06 HU HUE16183076A patent/HUE037325T2/hu unknown
- 2012-12-06 LT LTEP16183076.5T patent/LT3106176T/lt unknown
- 2012-12-06 PT PT161830765T patent/PT3106176T/pt unknown
- 2012-12-06 SI SI201231133T patent/SI3106176T1/en unknown
- 2012-12-06 EP EP16183076.5A patent/EP3106176B1/en not_active Revoked
- 2012-12-06 DK DK17185526.5T patent/DK3269386T3/da active
- 2012-12-06 NO NO16183076A patent/NO3106176T3/no unknown
- 2012-12-06 DK DK12795830.4T patent/DK2788023T3/en active
- 2012-12-06 DE DE202012012768.3U patent/DE202012012768U1/de not_active Expired - Lifetime
- 2012-12-06 EP EP20184308.3A patent/EP3785730B1/en active Active
- 2012-12-06 PL PL16183076T patent/PL3106176T3/pl unknown
- 2012-12-06 EP EP24167413.4A patent/EP4400115A3/en active Pending
- 2012-12-06 ES ES17185526T patent/ES2930458T3/es active Active
- 2012-12-06 PT PT171855265T patent/PT3269386T/pt unknown
- 2012-12-06 DK DK16183076.5T patent/DK3106176T3/en active
- 2012-12-06 ES ES20184308T patent/ES2987623T3/es active Active
- 2012-12-06 EP EP17185526.5A patent/EP3269386B1/en active Active
- 2012-12-06 RS RS20171241A patent/RS56709B1/sr unknown
- 2012-12-06 DK DK20184308.3T patent/DK3785730T3/da active
- 2012-12-06 EP EP12795830.4A patent/EP2788023B1/en active Active
- 2012-12-06 FI FIEP20184308.3T patent/FI3785730T3/fi active
- 2012-12-06 PL PL17185526.5T patent/PL3269386T3/pl unknown
- 2012-12-06 WO PCT/EP2012/074701 patent/WO2013083726A1/en active Application Filing
- 2012-12-06 ES ES16183076.5T patent/ES2647882T3/es active Active
2013
- 2013-12-09 DK DKBA201300193U patent/DK201300193U1/da not_active IP Right Cessation
- 2013-12-09 DK DKBA201300194U patent/DK201300194U1/da not_active Application Discontinuation
2017
- 2017-12-04 HR HRP20171871TT patent/HRP20171871T1/hr unknown
2018
- 2018-01-10 CY CY20181100033T patent/CY1119927T1/el unknown

Also Published As

Publication number	Publication date
NO3106176T3 (pt)	2018-03-10
HUE037325T2 (hu)	2018-08-28
EP3106176A1 (en)	2016-12-21
PT3269386T (pt)	2022-12-05
SI3106176T1 (en)	2018-04-30
DK3106176T3 (en)	2018-01-08
DK201300193U1 (da)	2014-01-17
ES2647882T3 (es)	2017-12-27
DK3785730T3 (da)	2024-05-06
EP3269386A1 (en)	2018-01-17
DK201300194U1 (da)	2014-01-17
CY1119927T1 (el)	2018-12-12
SMT201700607T1 (it)	2018-01-11
EP3785730A1 (en)	2021-03-03
ES2930458T3 (es)	2022-12-13
FI3785730T3 (fi)	2024-05-06
DK3269386T3 (da)	2022-10-24
EP4400115A2 (en)	2024-07-17
EP3785730B1 (en)	2024-04-24
EP3106176B1 (en)	2017-10-11
WO2013083726A1 (en)	2013-06-13
PL3106176T3 (pl)	2018-03-30
ES2987623T3 (es)	2024-11-15
EP2788023A1 (en)	2014-10-15
LT3106176T (lt)	2018-01-10
EP2788023B1 (en)	2016-11-02
DK2788023T3 (en)	2016-12-19
EP4400115A3 (en)	2024-10-23
RS56709B1 (sr)	2018-03-30
HRP20171871T1 (hr)	2018-01-12
DE202012012768U1 (de)	2014-01-21
EP3269386B1 (en)	2022-09-14
PL3269386T3 (pl)	2022-12-05

Publication	Publication Date	Title
HRP20171871T1 (hr)	2018-01-12	Spojevi aluminija za uporabu u terapeutskim proizvodima i cjepivima
BR302012003126S1 (pt)	2014-10-14	Configuração aplicada em empunhadura para intrumento médico
PL3033950T3 (pl)	2018-12-31	Pręty do zastosowania w wyrobach do palenia
PT2739268T (pt)	2019-01-28	Método e formulação para inalação
BR302012002887S1 (pt)	2014-10-14	Configuração aplicada em garrafa para cuidado pessoal
EP2718283A4 (en)	2014-10-29	INDAZOLE AND PYRROLOPYRIDINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF
BR112015002783A2 (pt)	2017-07-04	método e dispositivo para manipular artigos de higiene
IL229381B (en)	2018-04-30	Brilacitidine and its results for use in the treatment of mucositis
SG10201606161UA (en)	2016-09-29	Albumin Formulation and Use
CO6960537A2 (es)	2014-05-30	Paquete para productos absorbentes desechables y métodos relacionados
GB201218084D0 (en)	2012-11-21	Novel compounds and methods for use in medicine
BR112014009421A2 (pt)	2017-04-18	combinação terapêutica e método para tratamento
CO6781476A2 (es)	2013-10-31	Dispositivo modeable para terapia de lesiones y método
IL232809A (en)	2017-05-29	Carboxamides are preserved in position 2 isothiazolopyridine-2-carboxamides and used as drugs
PH12014500542A1 (en)	2014-04-21	Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
IL231096A (en)	2017-07-31	Theses are converted into 2- (novel-6-Iloxy) and used as pharmaceutical preparations
BRDI7103877S (pt)	2013-11-19	Configuração aplicada em expositor para produtos de beleza
GB201121833D0 (en)	2012-02-01	Aluminium compounds for use in therapeutics and vaccines
IL229936B (en)	2019-10-31	Albumin formulation and use
ES1074387Y (es)	2011-07-28	Aparato aplicador de producto para estetica y electromedicina
BRDI7105248S (pt)	2013-10-22	Configuração aplicada em andador
BR302012001635S1 (pt)	2014-08-19	Configuração aplicada em frasco para bebidas em geral
GB201112578D0 (en)	2011-08-31	Pharmaceutical preparation and use
BR302012005093S1 (pt)	2014-10-29	Configuração aplicada em embalagem para produtos de higiene pessoal
BRDI7105734S (pt)	2014-05-06	Configuração aplicada em tabuleiro para exercícios manuais em fisioterapia